DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr | ₹-1,218 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-974 Cr |
Mar2023 | ₹-629 Cr |
Mar2022 | ₹-1,276 Cr |
Mar2021 | ₹-1,040 Cr |
Mar2020 | ₹-1,218 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-974 Cr | Negative | |
Mar2023 | ₹-629 Cr | Negative | |
Mar2022 | ₹-1,276 Cr | Negative | |
Mar2021 | ₹-1,040 Cr | Negative | |
Mar2020 | ₹-1,218 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹113,613.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 3.2% |
10.3% |
11.7% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses